Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2M8V

Solution Structure and Activity Study of Bovicin HJ50, a Particular Type AII Lantibiotic

2M8V の概要
エントリーDOI10.2210/pdb2m8v/pdb
NMR情報BMRB: 19275
分子名称BovA (1 entity in total)
機能のキーワードlantibiotic, antibiotic
由来する生物種Streptococcus equinus
タンパク質・核酸の鎖数1
化学式量合計3440.09
構造登録者
Zhang, J.,Feng, Y.,Wang, J.,Zhong, J. (登録日: 2013-05-29, 公開日: 2014-05-21, 最終更新日: 2024-11-20)
主引用文献Zhang, J.,Feng, Y.,Teng, K.,Lin, Y.,Gao, Y.,Wang, J.,Zhong, J.
Type AII lantibiotic bovicin HJ50 with a rare disulfide bond: structure, structure-activity relationships and mode of action.
Biochem.J., 461:497-508, 2014
Cited by
PubMed Abstract: Lantibiotics are ribosomally synthesized antimicrobial peptides containing unusual amino acids. As promising alternatives to conventional antibiotics, they have a high potential for alleviating the problem of emergent antibiotic resistance, with possible applications in many industries that have antibacterial demand. Bovicin HJ50 is a type AII lantibiotic, the largest group of lantibiotics, comprising a linear N-terminal region and a globular C-terminal region. Interestingly, bovicin H50 has a disulfide bond that is rare in this group. Owing to limited information about the spatial structures of type AII lantibiotics, the functional regions of this type and the role of the disulfide bond are still unknown. In the present study, we resolved the solution structure of bovicin HJ50 using NMR spectroscopy. This is the first spatial structure of a type AII lantibiotic. Bovicin HJ50 exhibited high flexibility in aqueous solution, whereas varied rigidities were observed in the different rings with the conserved ring A being the most rigid. The charged residues Lys¹¹, Asp¹² and Lys³⁰, as well as the essential disulfide bond were critical for antimicrobial activity. Importantly, bovicin HJ50 showed not only peptidoglycan precursor lipid II-binding ability, but also pore-forming activity, which is significantly different from other bacteriostatic type AII lantibiotics, suggesting a novel antimicrobial mechanism.
PubMed: 24814218
DOI: 10.1042/BJ20131524
主引用文献が同じPDBエントリー
実験手法
SOLUTION NMR
構造検証レポート
Validation report summary of 2m8v
検証レポート(詳細版)ダウンロードをダウンロード

248636

件を2026-02-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon